DOCSLIB.ORG

Consolidated Statement of Investments, February 29, 2020 (Unaudited) Franklin K2 Alternative Strategies Fund

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Consolidated Statement of Investments, February 29, 2020 (Unaudited) Franklin K2 Alternative Strategies Fund FRANKLIN ALTERNATIVE STRATEGIES FUNDS Consolidated Statement of Investments, February 29, 2020 (unaudited) Franklin K2 Alternative Strategies Fund Shares/ Country Rights Value Common Stocks and Other Equity Interests 38.6% Aerospace & Defense 0.8% a Bombardier Inc., B Canada 609,589 $ 435,989 Heico Corp. United States 24,307 2,621,510 L3harris Technologies Inc. United States 3,492 690,473 Lockheed Martin Corp. United States 29 10,726 United Technologies Corp. United States 39,784 5,195,393 a Virgin Galactic Holdings Inc. United States 15,557 382,702 9,336,793 Air Freight & Logistics 0.4% a Atlas Air Worldwide Holdings Inc. United States 42,910 1,146,555 DSV Panalpina A/S Denmark 30,568 3,101,571 Expeditors International of Washington Inc. United States 576 40,562 FedEx Corp. United States 9,117 1,287,047 5,575,735 Airlines 0.2% Delta Air Lines Inc. United States 63,445 2,926,718 Auto Components 0.1% BorgWarner Inc. United States 33,050 1,044,380 Automobiles 0.3% b Harley-Davidson Inc. United States 108,798 3,315,075 Thor Industries Inc. United States 1,489 112,286 3,427,361 Banks 0.5% b Bank of America Corp. United States 114,633 3,267,041 Barclays PLC United Kingdom 108,406 207,759 Citigroup Inc. United States 159 10,090 Citizens Financial Group Inc. United States 144 4,563 b JPMorgan Chase & Co. United States 26,274 3,050,674 Popular Inc. Puerto Rico 160 7,677 6,547,804 Beverages 0.3% Davide Campari-Milano SpA Italy 315,714 2,639,614 a Primo Water Corp. United States 2,332 32,648 Remy Cointreau SA France 7,383 752,092 3,424,354 Biotechnology 2.3% AbbVie Inc. United States 140 11,999 a Acadia Pharmaceuticals Inc. United States 4,333 185,192 a Agios Pharmaceuticals Inc. United States 13,547 643,212 a,d,e Alder Biopharmaceuticals Inc., rts., 2/20/49 United States 50,624 44,549 a Alexion Pharmaceuticals Inc. United States 8,965 842,979 Amgen Inc. United States 52 10,386 a Amicus Therapeutics Inc. United States 56,310 537,479 a Apellis Pharmaceuticals Inc. United States 35,960 1,244,935 a Argenx SE, ADR Netherlands 6,535 923,918 a Assembly Biosciences Inc. United States 54,198 982,068 a Biogen Inc. United States 1,954 602,594 a BioMarin Pharmaceutical Inc. United States 30,706 2,774,901 a,e Black Diamond Therapeutics Inc. United States 10,447 281,965 a Blueprint Medicines Corp. United States 1,686 91,263 a CRISPR Therapeutics AG Switzerland 2,190 117,055 a,e Cytokinetics Inc. United States 14,108 196,665 a Deciphera Pharmaceuticals Inc. United States 1,986 105,735 a Denali Therapeutics Inc. United States 8,481 167,669 a Exact Sciences Corp. United States 17,802 1,441,072 a Fate Therapeutics Inc. United States 30,784 898,893 Quarterly Consolidated Statement of Investments | See Notes to the Consolidated Statements of Investments. 1 FRANKLIN ALTERNATIVE STRATEGIES FUNDS CONSOLIDATED STATEMENT OF INVESTMENTS (UNAUDITED) Franklin K2 Alternative Strategies Fund (continued) Shares/ Country Rights Value Common Stocks and Other Equity Interests (continued) Biotechnology (continued) a Gossamer Bio Inc. United States 16,762 $ 220,085 a Immunomedics Inc. United States 69,424 1,110,784 a,f Innovent Biologics Inc., 144A China 73,859 339,759 a Intercept Pharmaceuticals Inc. United States 2,972 273,246 a,e Invitae Corp. United States 8,635 175,981 a Madrigal Pharmaceuticals Inc. United States 3,939 339,424 a Mirati Therapeutics Inc. United States 8,575 767,377 a Momenta Pharmaceuticals Inc. United States 14,226 402,454 a Natera Inc. United States 35,848 1,358,818 a Neurocrine Biosciences Inc. United States 6,407 606,743 a Nextcure Inc. United States 5,435 226,966 a,b PDL BioPharma Inc. United States 141,208 480,107 a Principia Biopharma Inc. United States 10,247 661,546 a ProQR Therapeutics NV Netherlands 46,914 332,620 a Ra Pharmaceuticals Inc. United States 75,527 3,531,643 a Sage Therapeutics Inc. United States 9,681 455,007 a,b Sarepta Therapeutics Inc. United States 18,983 2,172,984 a SpringWorks Therapeutics Inc. United States 6,838 218,542 a Turning Point Therapeutics Inc. United States 9,959 493,668 a uniQure NV Netherlands 2,992 153,968 a Vertex Pharmaceuticals Inc. United States 7,393 1,656,254 a,e Zai Lab Ltd., ADR China 5,100 280,347 28,362,852 † Building Products 0.0% a Johnson Controls International PLC United States 306 11,190 Capital Markets 0.9% f Amundi SA, 144A France 26,813 1,926,685 f Anima Holding SpA, 144A Italy 102,616 453,048 Ares Capital Corp. United States 9,464 162,686 The Blackstone Group Inc., A United States 68,600 3,693,424 Bolsas y Mercados Espanoles SHMSF SA Spain 23,282 887,964 E*Trade Financial Corp. United States 21,586 988,207 Invesco Ltd. United States 727 10,469 LPL Financial Holdings Inc. United States 132 10,491 Moody's Corp. United States 10,097 2,423,583 T Rowe Price Group Inc. United States 93 10,975 TD Ameritrade Holding Corp. United States 23,401 988,224 11,555,756 Chemicals 0.7% a Ingevity Corp. United States 9,228 415,629 a Livent Corp. United States 42,762 381,865 LyondellBasell Industries NV, A United States 21 1,501 The Sherwin-Williams Co. United States 15,014 7,758,484 8,557,479 Commercial Services & Supplies 1.3% a Advanced Disposal Services Inc. United States 263,464 8,710,120 b Cintas Corp. United States 14,823 3,953,887 Republic Services Inc., A United States 33,464 3,020,460 15,684,467 Communications Equipment 0.2% Accton Technology Corp. Taiwan 67,000 361,779 Cisco Systems Inc. United States 14,893 594,678 a Lumentum Holdings Inc. United States 14,716 1,145,199 2,101,656 2 FRANKLIN ALTERNATIVE STRATEGIES FUNDS CONSOLIDATED STATEMENT OF INVESTMENTS (UNAUDITED) Franklin K2 Alternative Strategies Fund (continued) Shares/ Country Rights Value Common Stocks and Other Equity Interests (continued) Construction Materials 0.2% Cemex SAB de CV, ADR Mexico 72,599 $ 238,125 LafargeHolcim Ltd., B Switzerland 61,741 2,873,640 3,111,765 Containers & Packaging 0.6% Ball Corp. United States 105,664 7,445,085 a Crown Holdings Inc. United States 3,488 245,904 7,690,989 Distributors 0.1% b Pool Corp. United States 8,084 1,705,401 Diversified Financial Services 0.1% a ARYA Sciences Acquisition Corp. United States 20,099 241,188 a,d,g One Call Corp. United States 4,965 595,597 836,785 Diversified Telecommunication Services 1.1% AT&T Inc. United States 323 11,376 a Bandwidth Inc., A United States 8,673 545,445 f China Tower Corp. Ltd., H, 144A China 3,046,000 752,305 a Telecom Italia SpA Italy 77,432 43,065 Verizon Communications Inc. United States 223 12,078 a,b Zayo Group Holdings Inc. United States 343,589 12,022,180 13,386,449 Electric Utilities 1.5% a,d,h Bruce Mansfield, Contingent Distribution United States 6,394,000 — Duke Energy Corp. United States 129 11,829 EDP - Energias de Portugal SA Portugal 494,627 2,309,260 b El Paso Electric Co. United States 174,899 11,870,395 a Energy Harbor Corp. United States 144,987 4,066,885 Entergy Corp. United States 39 4,560 Evergy Inc. United States 174 11,371 FirstEnergy Corp. United States 155 6,902 18,281,202 Electrical Equipment 0.1% Eaton Corp. PLC United States 123 11,158 a Osram Licht AG Germany 16,862 759,776 770,934 Electronic Equipment, Instruments & Components 1.1% a Anixter International Inc. United States 47,885 4,669,266 a Coherent Inc. United States 1,506 193,837 Corning Inc. United States 17,897 427,023 a Flex Ltd. United States 124,218 1,380,062 a Tech Data Corp. United States 47,336 6,740,173 13,410,361 Entertainment 0.6% Cineplex Inc. Canada 146,933 3,611,339 a NetFlix Inc. United States 2,761 1,018,892 a Spotify Technology SA United States 1,223 167,697 The Walt Disney Co. United States 20,983 2,468,650 7,266,578 Equity Real Estate Investment Trusts (REITs) 0.1% Gaming and Leisure Properties Inc. United States 182 8,130 c Iron Mountain Inc. United States 374 11,373 Taubman Centers Inc. United States 15,765 820,726 VICI Properties Inc. United States 16,182 405,521 1,245,750 3 FRANKLIN ALTERNATIVE STRATEGIES FUNDS CONSOLIDATED STATEMENT OF INVESTMENTS (UNAUDITED) Franklin K2 Alternative Strategies Fund (continued) Shares/ Country Rights Value Common Stocks and Other Equity Interests (continued) Food & Staples Retailing 0.3% b Costco Wholesale Corp. United States 13,198 $ 3,710,486 Food Products 0.1% China Agri-Industries Holdings Ltd. Hong Kong 2,131,764 1,172,853 Chocoladefabriken Lindt & Spruengli AG Switzerland 6 522,033 Tyson Foods Inc., A United States 137 9,293 1,704,179 Health Care Equipment & Supplies 1.6% Abbott Laboratories United States 19,906 1,533,359 a Alcon Inc. Switzerland 3,112 190,766 a Align Technology Inc. United States 1,240 270,754 a Boston Scientific Corp. United States 44,647 1,669,351 Danaher Corp., W United States 5,988 865,745 a DexCom Inc. United States 6,821 1,882,596 a Edwards Lifesciences Corp.
Load more

Recommended publications
  • Rosuvastatin Calcium Patent Litigation
    IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE IN RE: ROSUVASTATIN CALCIUM MDL No. 08-1949-JJF PATENT LITIGATION, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 07-805-JJF-LPS MYLAN PHARMACEUTICALS INC., Defendant. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 07-806-JJF-LPS SUN PHARMACEUTICAL INDUSTRIES LTD. , Defendant. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 07-807-JJF-LPS SANDOZ INC., Defendant. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 07-808-JJF-LPS PAR PHARMACEUTICALS INC., Defendant. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 07-809-JJF-LPS APOTEX CORP., Defendants. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 07-810-JJF-LPS AUROBINDO PHARMA LTD. AND AUROBINDO PHARMA USA INC., Defendants. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 07-811-JJF-LPS COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC., Defendants. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v. Civil Action No. 08-359-JJF-LPS AUROBINDO PHARMA LTD. AND AUROBINDO PHARMA USA INC., Defendants. ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs, v.
    [Show full text]
  • Complaint in Action Manufacturing Co Inc Et Al
    SDMS DocID 2037769 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA ACTION MANUFACTURING CO., INC., ALCOA INC. f/k/a ALUMINUM COMPANY OF AMERICA, ARMSTRONG WORLD INDUSTRIES, INC., CIVIL ACTION ABB INC. f/k/a FISCHER & PORTER COMPANY, NO. 02- BECKETT COMPANY, L.P., GENERAL ELECTRIC COMPANY/RCA, GENERAL MOTORS CORPORATION, HAMILTON TECHNOLOGIES, INC. (BULOVA TECHNOLOGIES, L.L.C.), HAMILTON WATCH COMPANY, INC. (SWATCH GROUP U.S., INC.), HANDY & HARMAN , HAYFORK, L.P. f7k/a HAMILTON PRECISION METALS, INC., TUBE CO., HERCULES INCORPORATED, J.W. REX, LAFRANCE CORPORATION, LUCENT TECHNOLOGIES INC., PENFLEX, INC., PLYMOUTH TUBE COMPANY, REILLY PLATING COMPANY, SIEMENS ENERGY & AUTOMATION, INC. f/k/a MOORE PRODUCTS, CO., SUNROC CORPORATION, SYNTEX (USA), INC., UNISYS CORPORATION, AND VIZ LIQUIDATION TRUST Plaintiffs, v. SIMON WRECKING COMPANY, SIMON WRECKING COMPANY, INC., SIMON RESOURCES, INC., MID-STATE TRADING COMPANY, INC., S & S INVESTMENTS, INC., SCHWAB-SIMON REALTY CORPORATION, TRENTON REALTY CORPORATION, QUAKER CITY CHEMICALS, INC., CENTRAL PENN CHEMICALS, CENTRAL PENNSYLVANIA CHEMICALS, QUAKER CITY, INC., AROOOOOI J & J SPILL SERVICE & SUPPLIES, INC., J & J TRANSPORT, INC., A & A SEPTIC SERVICE, INC., CONTINENTAL VANGUARD, INC., LIGHTMAN DRUM COMPANY, LIGHTMAN DRUM CO., INC., RESOURCE TECHNOLOGY SERVICES, INC. BISHOP TUBE CO., ELECTRALLOY CORP., MERCEGAGLIA USA, INC., AMP INCORPORATED, TYCO ELECTRONICS CORPORATION, TYCO INTERNATIONAL (US), INC., TYCO INTERNATIONAL LTD., PETROCON INC., ANTROL INDUSTRIES, INC. MCCLAPJN PLASTICS, INC., LAVELLE AIRCRAFT COMPANY, AMETEK, INC., LEEDS AND NORTHRUP COMPANY, CSS INTERNATIONAL CORP., CSS METAL FABRICATION CORPORATION, CSS MACHINE & TOOL CO., INC., ECOLOGY SYSTEMS EQUIPMENT MANUFACTURING CO., INC., TECHNITROL, INC., FBF INDUSTRIES, INC., FBF, INC., ARK PRODUCTS CO, INC., MALCO.
    [Show full text]
  • Name and Title Company and Work Address Email Phone 2020
    Executive Leadership Institute for Women 2020 Philadelphia Class List Name and Title Company and Work Address Email Phone Cigna Michele Adams 215-761-1467 1601 Chestnut Street, TL 14A [email protected] Senior Director, Accounting Policy 267-418-3629 (c) Philadelphia, PA 19192 KPMG, LLP Lauren Albertson 267-256-3183 1601 Market Street [email protected] Senior Manager 215-817-0889 (c) Philadelphia, PA 07677 KPMG, LLP Rupali Amin 267-256-3221 1601 Market Street [email protected] Managing Director 267-210-4331 (c) Philadelphia, PA 07677 KPMG, LLP Abigail (Abby) Aungst 30 North Third Street, Suite 1000 [email protected] 717-507-7707 (c) Audit Senior Manager Harrisburg, PA 17101 Aramark Kelly Banaszak 267-671-4469 1101 Market St [email protected] Director of Communications 609-760-3332 (c) Philadelphia, PA 19107 Exelon Corporation Anne Bancroft 10 S. Dearborn St [email protected] 610-812-5454 (c) Associate General Counsel Chicago, IL 60603 Aramark Jennifer Bloom 215-238-8143 1101 Market St [email protected] Finance Director 215-779-1025 (c) Philadelphia, PA 19107 Geisinger Hannah Bobrowski 570-271-5417 100 North Academy Ave, MC 28-10 [email protected] Associate Vice President, Achieving Excellence 570-926-3071 (c) Danville, PA 17822 Independence Blue Cross Roslyn Boskett 1900 Market St, 7th Floor [email protected] 856-986-9814 (c) Director, Contact Center Philadelphia, PA 19103 KPMG, LLP Kelli Brown 1601 Market Street [email protected] 610-256-0628 (c) Senior Manager Audit Philadelphia, PA 07677
    [Show full text]
  • Usef-I Q2 2021
    Units Cost Market Value U.S. EQUITY FUND-I U.S. Equities 88.35% Domestic Common Stocks 10X GENOMICS INC 5,585 868,056 1,093,655 1ST SOURCE CORP 249 9,322 11,569 2U INC 301 10,632 12,543 3D SYSTEMS CORP 128 1,079 5,116 3M CO 11,516 2,040,779 2,287,423 A O SMITH CORP 6,897 407,294 496,998 AARON'S CO INC/THE 472 8,022 15,099 ABBOTT LABORATORIES 24,799 2,007,619 2,874,948 ABBVIE INC 17,604 1,588,697 1,982,915 ABERCROMBIE & FITCH CO 1,021 19,690 47,405 ABIOMED INC 9,158 2,800,138 2,858,303 ABM INDUSTRIES INC 1,126 40,076 49,938 ACACIA RESEARCH CORP 1,223 7,498 8,267 ACADEMY SPORTS & OUTDOORS INC 1,036 35,982 42,725 ACADIA HEALTHCARE CO INC 2,181 67,154 136,858 ACADIA REALTY TRUST 1,390 24,572 30,524 ACCO BRANDS CORP 1,709 11,329 14,749 ACI WORLDWIDE INC 6,138 169,838 227,965 ACTIVISION BLIZZARD INC 13,175 839,968 1,257,422 ACUITY BRANDS INC 1,404 132,535 262,590 ACUSHNET HOLDINGS CORP 466 15,677 23,020 ADAPTHEALTH CORP 1,320 39,475 36,181 ADAPTIVE BIOTECHNOLOGIES CORP 18,687 644,897 763,551 ADDUS HOMECARE CORP 148 13,034 12,912 ADOBE INC 5,047 1,447,216 2,955,725 ADT INC 3,049 22,268 32,899 ADTALEM GLOBAL EDUCATION INC 846 31,161 30,151 ADTRAN INC 892 10,257 18,420 ADVANCE AUTO PARTS INC 216 34,544 44,310 ADVANCED DRAINAGE SYSTEMS INC 12,295 298,154 1,433,228 ADVANCED MICRO DEVICES INC 14,280 895,664 1,341,320 ADVANSIX INC 674 15,459 20,126 ADVANTAGE SOLUTIONS INC 1,279 14,497 13,800 ADVERUM BIOTECHNOLOGIES INC 1,840 7,030 6,440 AECOM 5,145 227,453 325,781 AEGLEA BIOTHERAPEUTICS INC 287 1,770 1,998 AEMETIS INC 498 6,023 5,563 AERSALE CORP
    [Show full text]
  • Wilmington Funds Holdings Template DRAFT
    Wilmington Large-Cap Strategy Fund as of 5/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS APPLE INC 4.97% MICROSOFT CORP 4.69% AMAZON.COM INC 3.45% FACEBOOK INC 1.99% ALPHABET INC 1.80% ALPHABET INC 1.77% BERKSHIRE HATHAWAY INC 1.48% JPMORGAN CHASE & CO 1.35% TESLA INC 1.20% JOHNSON & JOHNSON 1.12% UNITEDHEALTH GROUP INC 0.98% VISA INC 0.96% NVIDIA CORP 0.96% BANK OF AMERICA CORP 0.89% HOME DEPOT INC/THE 0.87% WALT DISNEY CO/THE 0.82% MASTERCARD INC 0.80% PAYPAL HOLDINGS INC 0.77% EXXON MOBIL CORP 0.68% PROCTER & GAMBLE CO/THE 0.67% COMCAST CORP 0.66% ADOBE INC 0.62% INTEL CORP 0.59% VERIZON COMMUNICATIONS INC 0.59% CISCO SYSTEMS INC 0.57% CHEVRON CORP 0.55% PFIZER INC 0.54% NETFLIX INC 0.54% AT&T INC 0.53% SALESFORCE.COM INC 0.53% ABBOTT LABORATORIES 0.51% ABBVIE INC 0.50% MERCK & CO INC 0.48% WELLS FARGO & CO 0.48% BROADCOM INC 0.47% THERMO FISHER SCIENTIFIC INC 0.47% ACCENTURE PLC 0.46% CITIGROUP INC 0.45% MCDONALD'S CORP 0.44% TEXAS INSTRUMENTS INC 0.44% COCA-COLA CO/THE 0.44% HONEYWELL INTERNATIONAL INC 0.44% LINDE PLC 0.43% MEDTRONIC PLC 0.43% NIKE INC 0.43% ELI LILLY & CO 0.42% PEPSICO INC 0.42% UNITED PARCEL SERVICE INC 0.41% WALMART INC 0.40% DANAHER CORP 0.40% UNION PACIFIC CORP 0.40% QUALCOMM INC 0.38% BRISTOL-MYERS SQUIBB CO 0.37% ORACLE CORP 0.37% LOWE'S COS INC 0.36% BLACKROCK INC 0.35% CATERPILLAR INC 0.35% AMGEN INC 0.35% BOEING CO/THE 0.35% MORGAN STANLEY 0.35% COSTCO WHOLESALE CORP 0.35% RAYTHEON TECHNOLOGIES CORP 0.34% STARBUCKS CORP 0.34% GOLDMAN SACHS GROUP INC/THE 0.34% GENERAL ELECTRIC
    [Show full text]
  • Securities and Exchange Commission Washington, D.C
    SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------- FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2001 Commission file number 1-1398 UGI UTILITIES, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) Pennsylvania 23-1174060 (STATE OR OTHER JURISDICTION (I.R.S. EMPLOYER IDENTIFICATION NO.) OF INCORPORATION OR ORGANIZATION) 100 Kachel Boulevard, Suite 400, Green Hills Corporate Center Reading, PA 19607 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) (610) 796-3400 (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE) SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: None SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: None INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS) AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS. YES X . NO . ----- ---- Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X] At December 1, 2001 there were 26,781,785 shares of UGI Utilities Common Stock, par value $2.25 per share, outstanding, all of which were held, beneficially and of record, by UGI Corporation.
    [Show full text]
  • Ugi Utilities Inc
    UGI UTILITIES INC FORM 10-K405 (Annual Report (Regulation S-K, item 405)) Filed 12/26/1996 For Period Ending 9/30/1996 100 KACHEL BOULEVARD SUITE 400 GREEN HILLS CORPORATE Address CENTER VALLEY FORGE, Pennsylvania 19607 Telephone 610-796-3400 CIK 0000100548 Fiscal 09/30 Year SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 1996 Commission file number 1-1398 UGI UTILITIES, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) Pennsylvania 23-1174060 (STATE OR OTHER JURISDICTION (I.R.S. EMPLOYER IDENTIFICATION NO.) OF INCORPORATION OR ORGANIZATION) 100 Kachel Boulevard, Suite 400, Green Hills Corporate Center Reading, PA 19607 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) (610) 796-3400 (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE) SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: None SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT: None INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS) AND (2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS. YES X . NO . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • United States Court of Appeals for the Federal Circuit
    United States Court of Appeals for the Federal Circuit __________________________ IN RE ROSUVASTATIN CALCIUM PATENT LITIGATION __________________________ ASTRAZENECA UK LIMITED, IPR PHARMACEUTICALS INC., AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plaintiffs-Appellees, v. AUROBINDO PHARMA LIMITED, Defendant-Appellant, AND MYLAN PHARMACEUTICALS INC., Defendant-Appellant, AND APOTEX CORP., Defendant-Appellant, AND COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC., Defendants-Appellants, AND SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendant-Appellant, ASTRAZENECA v. AUROBINDO 2 AND TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant, AND PAR PHARMACEUTICAL, INC., Defendant-Appellant, AND SANDOZ, INC., Defendant. __________________________ 2010-1460,-1461,-1462,-1463,-1464,-1465,-1466,-1467, - 1468,-1469,-1470,-1471,-1472,-1473 __________________________ Appeal from the United States District Court for the District of Delaware in case nos. 08-MD-1949, 07-CV-0810, 07-CV-0805, 07-CV-0809, 07-CV-0811, 07-CV-0806, 08-CV- 0426, and 07-CV-0808, Judge Joseph J. Farnan, Jr. ___________________________ Decided: December 14, 2012 ___________________________ CHARLES E. LIPSEY, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, of Reston, Virginia, argued for plaintiff-appellee. With him on the brief were KENNETH M. FRANKEL, and YORK M. FAULKNER. Of counsel on the brief were FORD F. FARABOW, JR., and HOWARD W. LEVINE, of Washington, DC, MARY K. FERGUSON, of Cambridge, Massa- chuettes, JOHN D. LIVINGSTONE, of Atlanta, Georgia, MARY W. BOURKE, Connolly Bove Lodge & Hutz, LLP, of Wilming- 3 ASTRAZENECA v. AUROBINDO ton, Delaware, HENRY J. RENK, Fitzpatrick, Cella, Harper & Scinto, of New York, New York, THOMAS STEVENS and JUDY YUN, AstraZeneca Pharmaceuticals, LP, of Wilmington, Delaware. ROBERT B. BREISBLATT, Katten Muchin Rosenman, LLP, of Chicago, Illinois, argued for defendant-appellant.
    [Show full text]
  • Investment Holdings As of December 31, 2019
    Investment Holdings As of December 31, 2019 Transparency of the Montana Investment Holdings The Montana Board of Investment’s holdings file is a comprehensive listing of all manager funds, separately managed and commingled, and aggregated security positions. Securities are organized across common categories: Pension Pool, Asset Class, Manager Fund, Aggregated Individual Holdings, and Non‐Pension Pools. Market values shown are in U.S. dollars. The market values shown in this document are for the individual investment holdings only and do not include any information on accounts for receivables or payables. Aggregated Individual Holdings represent securities held at our custodian bank and individual commingled accounts. The Investment Holdings Report is unaudited and may be subject to change. The audited Unified Investment Program Financial Statements will be made available once the Legislative Audit Division issues the Audit Opinion. Once issued, the Legislative Audit Division will have the Audit Opinion available online at http://leg.mt.gov/css/publications/audit/reports.asp and the complete audited financial statements will also be available on the Board’s website http://investmentmt.com/AnnualReportsAudits. Additional information can be found at www.investmentmt.com Table of Contents Consolidated Asset Pension Pool (CAPP) 4 CAPP ‐ Domestic Equities 5 CAPP – Core Fixed Income 24 CAPP ‐ International Equities 29 CAPP ‐ Private Equities 45 CAPP ‐ Real Estate 48 CAPP ‐ Natural Resources 50 CAPP – Non Core Fixed Income 52 CAPP ‐ Cash 62 Short
    [Show full text]
  • Look Who Said Goodbye to the U.S.A
    LOOK WHO SAID GOODBYE TO THE U.S.A. Here is a list of companies we've confirmed are "Exporting America." These are U.S. companies either sending American jobs overseas, or choosing to employ cheap overseas labor, instead of American workers. 3Com B Continued… 3M Bechtel BellSouth A Best Buy Accenture Black & Decker Adaptec BMC Software ADC Boeing Adobe Systems Brocade Advanced Energy Industries Bumble Bee Aetna Affiliated Computer Services C A.G. Edwards Cadence Design Systems Agere Systems Capital One Agilent Tech. Carrier AIG Cendant Alamo Rent A Car Cerner Corporation Albertson's Charles Schwab Allen Systems Group ChevronTexaco Alliance Semiconductor CIBER Allstate Ciena Alpha Thought Global Cigna Amazon.com Circuit City, Inc. AMD Cisco Systems American Express Citigroup American Household CNA American Management Systems Coca-Cola American Standard Cognizant Technology Solutions Amphenol Corp. Columbia House Analog Devices Comcast Holdings Andrew Corp. Computer Associates Anheuser-Busch Computer Sciences Corporation AOL CompuServe Apple Continental Airlines Applied Materials Convergys A.T. Cross Company Cooper Tire & Rubber AT&T Cooper Tools AT&T Wireless Countrywide Financial A.T. Kearney COVAD Comm. Automatic Data Processing CSX Avanade Cummins Avery Dennison Cypress Semiconductor B D Bank of America Dana Corporation Bank of New York Delco Remy Bank One Dell Computer BearingPoint Delphi Bear Stearns Delta Air Lines D Continued…. H Continued…. Direct TV Humana Discover Document Sciences Corp. I Dow Chemical IBM Dun & Bradstreet iGate
    [Show full text]
  • New Covenant Growth Fund
    SCHEDULE OF INVESTMENTS (Unaudited) March 31, 2020 New Covenant Growth Fund Market Value Market Value Description Shares ($ Thousands) Description Shares ($ Thousands) COMMON STOCK — 96.0% COMMON STOCK (continued) Bosnia and Herzegovina — 0.0% IMAX * 2,244 $ 20 RenaissanceRe Holdings Ltd. 248 $ 37 Intelsat * 8,389 13 – Interpublic Group of Cos Inc/The 8,487 137 Canada — 0.1% Iridium Communications * 366 8 Lululemon Athletica Inc * 1,014 192 – John Wiley & Sons Inc, Cl A 236 9 Cayman Islands — 0.0% Liberty Broadband, Cl A * 113 12 Herbalife * 1,088 31 Lions Gate Entertainment, Cl A * 7,278 44 – Ireland — 1.0% Live Nation Entertainment Inc * 181 8 Accenture PLC, Cl A 11,297 1,844 Match Group * 703 46 Jazz Pharmaceuticals PLC * 616 62 Meredith 1,401 17 Mallinckrodt * 13,812 27 MSG Networks * 2,988 31 Medtronic PLC 19,976 1,801 New York Times, Cl A 1,515 47 NortonLifeLock 13,065 245 Nexstar Media Group, Cl A 455 26 Perrigo Co PLC 211 10 Omnicom Group Inc 10,137 557 Scholastic 1,266 32 3,989 – Shenandoah Telecommunications 1,286 63 Puerto Rico — 0.0% Sirius XM Holdings 7,153 35 Popular Inc 1,507 53 – Spotify Technology SA * 608 74 Switzerland — 0.0% Sprint Corp * 2,200 19 Garmin Ltd 1,092 82 Take-Two Interactive Software Inc * 830 98 – TechTarget * 1,986 41 United Kingdom — 0.2% TEGNA 3,052 33 Aon PLC 2,921 482 T-Mobile US Inc * 2,824 237 Healthpeak Properties 9,384 224 Twitter Inc * 7,369 181 706 – Verizon Communications Inc 62,462 3,356 United States — 94.7% ViacomCBS, Cl B 1,000 14 Communication Services — 8.3% Walt Disney Co/The 26,709
    [Show full text]
  • Triumph Group Annual Report 2020
    Triumph Group Annual Report 2020 Form 10-K (NYSE:TGI) Published: May 28th, 2020 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-12235 Triumph Group, Inc. (Exact name of registrant as specified in its charter) Delaware 51-0347963 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 899 Cassatt Road, Suite 210, Berwyn, Pennsylvania 19312 (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: (610) 251-1000 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share TGI New York Stock Exchange Purchase rights New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934. Yes ☐ No ☒ Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]